Selecting an Appropriate Surgical Treatment Instead of Carotid Artery Stenting Alone According to the Patient’s Risk Factors Contributes to Reduced Perioperative Complications in Patients with Internal Carotid Stenosis: A Single Institutional Retrospective Analysis
-
- SATO Kimitoshi
- Department of Neurosurgery, Kitasato University School of Medicine
-
- SUZUKI Sachio
- Department of Neurosurgery, Kitasato University School of Medicine
-
- YAMADA Masaru
- Department of Neurosurgery, Kitasato University School of Medicine
-
- OKA Hidehiro
- Department of Neurosurgery, Kitasato University School of Medicine
-
- KURATA Akira
- Department of Neurosurgery, Kitasato University School of Medicine
-
- OKAMOTO Hirotsugu
- Department of Anesthesiology, Kitasato University School of Medicine
-
- FUJII Kiyotaka
- Department of Neurosurgery, Kitasato University School of Medicine
-
- KUMABE Toshihiro
- Department of Neurosurgery, Kitasato University School of Medicine
この論文をさがす
抄録
This retrospective study was aimed to compare the perioperative complications for internal carotid artery stenosis (ICS) in a Japanese single institute between the use of carotid artery stenting (CAS) alone or the use of an appropriate individualized treatment method allowing either carotid endarterectomy (CEA) or CAS based on patient risk factors. Based on the policy at our hospital, only CAS was performed on patients (n = 33) between January 2005 and November 2009. From December 2009 to December 2012, either CEA or CAS (tailored treatment) was selected for patients (n = 61) based on individual patient risk factors. CEA was considered the first-line treatment in all cases. In high-risk CEA cases, CAS was performed instead (n = 11), whereas in low-risk CEA cases, CEA was performed (n = 19). Further, in moderate-risk CEA cases based on own criteria, CAS was considered first, whereas for high-risk CAS cases, CEA was performed (n = 17). For low-risk CAS cases, CAS was performed (n = 9). Perioperative clinical complications (any stroke, myocardial infarction, or death within 30 days) were compared between both periods. Significantly reduced perioperative complications were observed during the tailored period (4/61 sites, 6.6%) as compared with the CAS period (8/33 sites, 24.2%) [Fisher’s exact test p = 0.022; odds ratio, 4.56 (CAS/tailored); 95% confidence interval, 1.26–16.5]. Selecting an appropriate individualized treatment method according to patient risk factors, as opposed to adhering to a single treatment approach such as CAS, may contribute to improved overall outcomes in patients with ICS.
収録刊行物
-
- Neurologia medico-chirurgica
-
Neurologia medico-chirurgica 55 (2), 124-132, 2015
一般社団法人 日本脳神経外科学会
